Live Oak Health Sciences
Live Oak Health Sciences invests primarily in the stocks of companies within the healthcare sector. The fund may include small-cap companies but is more heavily weighted toward large- and mid-caps.
Inception Date
Jun 29 2001Number of Holdings
32Investment Goal
Live Oak Health Sciences seeks long-term capital growth.
Investment Approach
The investment process for Live Oak involves identifying what the Manager believes to be the most attractive areas within healthcare and narrowing the search to individual stocks. The stock selection process is based on a quantitative and qualitative analysis of individual companies’ fundamentals such as valuation, capital deployment, and competitive advantages. The Manager invests with a long-term focus, with an emphasis on the durability of the business, and tends to have portfolio turnover that is lower than that of peers.
Literature
|
Live Oak Health Sciences Fact Sheet
|
View |
|
Live Oak Health Sciences Summary Prospectus
|
View |
|
Annual Report
|
View |
|
Semi-Annual Report
|
View |
|
Statutory Prospectus
|
View |
|
Statement of Additional Information (SAI)
|
View |
Fund Performance
| LOGSX | S&P 500 Healthcare Index | |
|---|---|---|
| 1 Year | 3.57 | 4.17 |
| 3 Year | 9.11 | 12.05 |
| 5 Year | 7.96 | 12.23 |
| 10 Year | 9.87 | 12.89 |
| Inception Date | Jun 29, 2001 |
| LOGSX | S&P 500 Healthcare Index | |
|---|---|---|
| 1 Year | -1.95 | -3.70 |
| 3 Year | 11.41 | 15.41 |
| 5 Year | 7.94 | 11.82 |
| 10 Year | 9.73 | 12.87 |
| Inception Date | Jun 29, 2001 |
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an Investor’s shares, when redeemed, may not be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. For performance data current to the most recent month end, please call 1-888-462-5386.
The S&P 500 Healthcare Index imposes comprises those companies included in the S&P 500 that are classified as members of the GICS health care sector. One cannot invest directly in an index.
Daily
Closing price as of 05/26/2023| Share Price | $19.82 |
| Change | -0.11% |
| Year-to-Date Performance | -8.28% |
Fund Managers
.jpeg)
Portfolio Manager
Managing Member
experience
with Oak
Portfolio Holdings
As of Mar 31, 2023
| Holding | Ticker | |
|---|---|---|
| 4.8 | Regeneron Pharmaceuticals, Inc. | REGN |
| 4.6 | Amgen, Inc. | AMGN |
| 4.1 | AmerisourceBergen Corp. | ABC |
| 4.0 | Cardinal Health, Inc. | CAH |
| 3.7 | Merck & Co., Inc. | MRK |
| 3.6 | McKesson Corp. | MCK |
| 3.5 | AbbVie, Inc. | ABBV |
| 3.5 | Bio-Rad Laboratories, Inc. | BIO |
| 3.3 | Ensign Group, Inc./The | ENSG |
| 3.2 | Vertex Pharmaceuticals, Inc. | VRTX |
| 3.2 | Medtronic PLC | MDT |
| 3.1 | Exelixis, Inc. | EXEL |
| 3.1 | Laboratory Corp of America Holdings | LH |
| 3.1 | United Therapeutics Corp. | UTHR |
| 3.0 | Intuitive Surgical, Inc. | ISRG |
| 3.0 | Moderna, Inc. | MRNA |
| 2.9 | Elevance Health, Inc. | ELV |
| 2.9 | UnitedHealth Group, Inc. | UNH |
| 2.8 | Humana, Inc. | HUM |
| 2.7 | Jazz Pharmaceuticals PLC | JAZZ |
| 2.6 | Biogen, Inc. | BIIB |
| 2.6 | Cigna Group/The | CI |
| 2.4 | Ironwood Pharmaceuticals, Inc. | IRWD |
| 2.4 | Pfizer, Inc. | PFE |
| 2.4 | Stryker Corp. | SYK |
| 2.3 | Molina Healthcare, Inc. | MOH |
| 2.1 | CVS Health Corp. | CVS |
| 2.1 | Gilead Sciences, Inc. | GILD |
| 2.0 | Johnson & Johnson | JNJ |
| 2.0 | Novartis AG | NVS |
| 1.9 | Quest Diagnostics, Inc. | DGX |
| 1.8 | Centene Corp. | CNC |
Important Risk Information:
Mutual fund investing involves risk, including the possible loss of principal. Funds that emphasize investments in technology generally will experience greater price volatility. There are additional risks associated with investing in a single-sector fund with a limited number of holdings versus a more broadly diversified portfolio, including greater sensitivity to economic, political, or regulatory developments impacting the sector. Diversification does not ensure a profit or guarantee against loss. Funds that emphasize investments in smaller or mid-sized companies may experience greater price volatility. Funds that emphasize investments in larger companies may underperform and be unable to respond quickly to new competitive challenges and may not be able to attain the high growth rate of successful smaller companies. Growth investing has the risk of being more sensitive to changes in current or expected earnings.
The security holdings are presented to illustrate examples of the securities that the fund has bought an the diversity of areas in which the funds may invest, and may not be representative of the fund's current or future investments. Portfolio holdings are subject to change and should not be considered investment advice. Current and future portfolio holdings are subject to risk.